Dow Up 0.47% Nasdaq Up 0.50%

Advaxis, Inc. (ADXS)

-NasdaqCM
3.24 Up 0.02(0.62%) 10:14AM EDT - Nasdaq Real Time Price
Prev Close:3.22
Open:3.20
Bid:3.19 x 100
Ask:3.21 x 100
1y Target Est:13.50
Beta:1.16
Next Earnings Date:N/A
Day's Range:3.15 - 3.25
52wk Range:2.46 - 7.59
Volume:71,610
Avg Vol (3m):233,020
Market Cap:63.24M
P/E (ttm):N/A
EPS (ttm):-2.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXSUp 0.62%63.24M
BVTI 0.00%N/A
DNDNDown 0.34%229.26M
VICLDown 1.61%102.87M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):62.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-14) :-1.16
Quarterly EPS Est (Oct-14) :-0.29
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical development stage biotechnology company, focuses on developing immunotherapies for cancer and infectious diseases. The company’s Lm -LLO immunotherapy platform technology stimulates the immune system to induce antige... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback